These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2767017)

  • 21. Effects of gamma-vinyl-GABA on the human electroencephalogram.
    Hammond EJ; Wilder BJ
    Neuropharmacology; 1985 Oct; 24(10):975-84. PubMed ID: 2999635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vigabatrin: no microvacuoles in a human brain.
    Pedersen B; Højgaard K; Dam M
    Epilepsy Res; 1987 Jan; 1(1):74-6. PubMed ID: 3504385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gamma-vinyl GABA (vigabatrin): clinical experience in adult and adolescent patients with intractable epilepsy.
    Reynolds EH
    Epilepsia; 1992; 33 Suppl 5():S30-4; discussion S34-5. PubMed ID: 1425498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-blind study of gamma-vinyl GABA in patients with refractory epilepsy.
    Rimmer EM; Richens A
    Lancet; 1984 Jan; 1(8370):189-90. PubMed ID: 6141335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GABA in epilepsy: the pharmacologic basis.
    Gale K
    Epilepsia; 1989; 30 Suppl 3():S1-11. PubMed ID: 2548836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One to three day dose intervals during subchronic treatment of epileptic gerbils with gamma-vinyl GABA: anticonvulsant efficacy and alterations in regional brain GABA levels.
    Löscher W; Frey HH
    Eur J Pharmacol; 1987 Nov; 143(3):335-42. PubMed ID: 3691661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacology of vigabatrin.
    Sabers A; Gram L
    Pharmacol Toxicol; 1992 Apr; 70(4):237-43. PubMed ID: 1608908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of vigabatrin in the long-term treatment of refractory epilepsy.
    Remy C; Beaumont D
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):125S-129S. PubMed ID: 2757903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental studies and controlled clinical testing of valproate and vigabatrin.
    Gram L
    Acta Neurol Scand; 1988 Oct; 78(4):241-70. PubMed ID: 3146860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vigabatrin as an anticonvulsant against pentylenetetrazol seizures.
    Sayin U; Cengiz S; Altug T
    Pharmacol Res; 1993 Dec; 28(4):325-31. PubMed ID: 8140032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term antiepileptic efficacy of vigabatrin in drug-refractory epilepsy in mentally retarded patients. A 5-year follow-up study.
    Pitkänen A; Ylinen A; Matilainen R; Luukkainen R; Mervaala E; Seppänen R; Ruutiainen T; Riekkinen PJ
    Arch Neurol; 1993 Jan; 50(1):24-9. PubMed ID: 8418797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis of European placebo controlled studies of vigabatrin in drug resistant epilepsy.
    Mumford JP; Dam M
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):101S-107S. PubMed ID: 2667602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vigabatrin (gamma-vinyl-GABA): neuropathologic evaluation in five patients.
    Sivenius J; Paljärvi L; Vapalahti M; Nousiainen U; Riekkinen PJ
    Epilepsia; 1993; 34(1):193-6. PubMed ID: 8422859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vigabatrin in chronic epilepsy: a 7-year follow-up study of responder patients.
    Cocito L; Maffini M; Loeb C
    Seizure; 1993 Dec; 2(4):301-7. PubMed ID: 8162400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vigabatrin: rational treatment for chronic epilepsy.
    Ring HA; Heller AJ; Farr IN; Reynolds EH
    J Neurol Neurosurg Psychiatry; 1990 Dec; 53(12):1051-5. PubMed ID: 2292696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vigabatrin in the treatment of epilepsy: a long-term follow-up study.
    Tartara A; Manni R; Galimberti CA; Mumford JP; Iudice A; Perucca E
    J Neurol Neurosurg Psychiatry; 1989 Apr; 52(4):467-71. PubMed ID: 2661725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vigabatrin in the treatment of epilepsy: a double-blind, placebo-controlled study.
    Tartara A; Manni R; Galimberti CA; Hardenberg J; Orwin J; Perucca E
    Epilepsia; 1986; 27(6):717-23. PubMed ID: 3536469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vigabatrin in the treatment of epilepsy in children.
    Livingston JH; Beaumont D; Arzimanoglou A; Aicardi J
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):109S-112S. PubMed ID: 2757901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Six-year follow-up study on the efficacy and safety of vigabatrin in patients with epilepsy.
    Tartara A; Manni R; Galimberti CA; Morini R; Mumford JP; Iudice A; Perucca E
    Acta Neurol Scand; 1992 Sep; 86(3):247-51. PubMed ID: 1414241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double-blind dose reduction study of vigabatrin in complex partial epilepsy.
    Sivenius MR; Ylinen A; Murros K; Matilainen R; Riekkinen P
    Epilepsia; 1987; 28(6):688-92. PubMed ID: 3319536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.